Morgan Stanley analyst Vikram Purohit assumes coverage on Sage Therapeutics (NASDAQ: SAGE) with a Equal-weight rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE